109 related articles for article (PubMed ID: 1880909)
1. Anthracycline antibiotic 2-hydroxyaclacinomycins. I. 2-Hydroxyaclacinomycin-producing recombinant obtained from aclacinomycin-blocked mutants of Streptomyces galilaeus by a technique of protoplast fusion.
Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
Jpn J Antibiot; 1991 Mar; 44(3):269-76. PubMed ID: 1880909
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hydroxyaclacinomycins A and B by a new recombinant strain and their antitumor activities.
Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
Jpn J Antibiot; 1991 Mar; 44(3):277-86. PubMed ID: 1880910
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutants.
Ylihonko K; Hakala J; Niemi J; Lundell J; Mäntsälä P
Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1359-65. PubMed ID: 8081501
[TBL] [Abstract][Full Text] [Related]
4. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
Kim HS; Hong YS; Kim YH; Yoo OJ; Lee JJ
J Antibiot (Tokyo); 1996 Apr; 49(4):355-60. PubMed ID: 8641998
[TBL] [Abstract][Full Text] [Related]
5. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
Kim HS; Kim YH; Yoo OJ; Lee JJ
Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
[TBL] [Abstract][Full Text] [Related]
7. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
[TBL] [Abstract][Full Text] [Related]
8. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
Hwang CK; Kim HS; Hong YS; Kim YH; Hong SK; Kim SJ; Lee JJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1616-20. PubMed ID: 7492117
[TBL] [Abstract][Full Text] [Related]
9. Hybrid anthracyclines from a genetically engineered Streptomyces galilaeus mutant.
Kunnari TJ; Ylihonko KP; Klika KD; Mäntsälä PI; Hakala JM
J Org Chem; 2000 May; 65(10):2851-5. PubMed ID: 10814169
[TBL] [Abstract][Full Text] [Related]
10. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin.
Räty K; Kunnari T; Hakala J; Mäntsälä P; Ylihonko K
Mol Gen Genet; 2000 Sep; 264(1-2):164-72. PubMed ID: 11016846
[TBL] [Abstract][Full Text] [Related]
11. Cloning of aklavinone biosynthesis genes from Streptomyces galilaeus.
Tsukamoto N; Fujii I; Ebizuka Y; Sankawa U
J Antibiot (Tokyo); 1992 Aug; 45(8):1286-94. PubMed ID: 1399850
[TBL] [Abstract][Full Text] [Related]
12. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A
J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429
[TBL] [Abstract][Full Text] [Related]
13. Modifications of aclacinomycin T by aclacinomycin methyl esterase (RdmC) and aclacinomycin-10-hydroxylase (RdmB) from Streptomyces purpurascens.
Wang Y; Niemi J; Airas K; Ylihonko K; Hakala J; Mäntsälä P
Biochim Biophys Acta; 2000 Jul; 1480(1-2):191-200. PubMed ID: 11004563
[TBL] [Abstract][Full Text] [Related]
14. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
Hoshino T; Sekine Y; Fujiwara A
J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152
[TBL] [Abstract][Full Text] [Related]
15. New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1.
Tobe H; Yoshimoto A; Ishikura T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Dec; 35(12):1641-5. PubMed ID: 6962794
[TBL] [Abstract][Full Text] [Related]
16. Engineering anthracycline biosynthesis toward angucyclines.
Metsä-Ketelä M; Palmu K; Kunnari T; Ylihonko K; Mäntsälä P
Antimicrob Agents Chemother; 2003 Apr; 47(4):1291-6. PubMed ID: 12654660
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the antitumor antibiotic aclacinomycin A].
Zhang H; Wang D; Xu S; Ye Y; Chen P
Wei Sheng Wu Xue Bao; 1991 Jun; 31(3):247-50. PubMed ID: 1862654
[TBL] [Abstract][Full Text] [Related]
18. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius.
Schumann G; Stengel C; Eckardt K; Ihn W
J Basic Microbiol; 1986; 26(4):249-55. PubMed ID: 3464736
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mutations in aclacinomycin A-non-producing Streptomyces galilaeus strains with altered glycosylation patterns.
Räty K; Hautala A; Torkkell S; Kantola J; Mäntsälä P; Hakala J; Ylihonko K
Microbiology (Reading); 2002 Nov; 148(Pt 11):3375-3384. PubMed ID: 12427929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
